From: Circulating tumour DNA alterations: emerging biomarker in head and neck squamous cell carcinoma
Mutated genes in ctDNA | Studies |
---|---|
TP53 | Burgener et al. [13]; Flach et al. [37]; Galot et al. [43]; Khandelwal et al. [69]; Kogo et al. [72]; Mes et al. [99]; Perdomo et al. [115]; Porter et al. [118]; van Gink et al. [156]; Wilson et al. [165] |
PIK3CA | Burgener et al. [13]; Galot et al. [43]; Liebs et al. [83]; Porter et al. [118], |
MYC | |
CDKN2A | |
NRAS | |
EGFR | |
NOTCH1 | |
FAT1 | |
BRCA1, KIT, BRAF, ESR1, FGFR2, FGFR3, MAP2K1, ARID1A, ATM, MET | Wilson et al. [165], |
ACACA, ATR, LAMA2, SMARCA4, RELN, PDGFRA, EZH2 | Liebs et al. [83], |
CASP8, NSD1, KMT2D, | Mes et al. [99], |
KRAS, HRAS | Braig et.al. [12], |
GRIN3A | Burgener et al. [13], |
FBXW7 | Khandelwal et al. [69], |
Methylated genes in ctDNA | |
 CDKN2A | |
 DAPK1 | |
 CCNA1, DAPK, CDH8, TIMP3 | Jesus et al. [29], |
 PENK, NXPH1, ZIK1, TBXT, CDO1 | Patel et al. [112], |
 EDNRB, p16, DCC | Mydlarz et al. [102], |
 RASSF1, DLEC1, UCHL1 | Tian et al. [150], |
 MGMT, GSTP1 | Sanchez et al. [127], |
 SHOX2, SEPT9 | Schröck et al. [132], |